See more : ML System S.A. (MLS.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Ventura Cannabis & Wellness Corporation (CVHIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ventura Cannabis & Wellness Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Zhejiang Qianjiang Motorcycle Co., Ltd. (000913.SZ) Income Statement Analysis – Financial Results
- CRCC High-Tech Equipment Corporation Limited (1786.HK) Income Statement Analysis – Financial Results
- Nordnet AB (publ) (SAVE.ST) Income Statement Analysis – Financial Results
- Ratch Group Public Company Limited (RATCH-R.BK) Income Statement Analysis – Financial Results
- YFC-Boneagle Electric Co., Ltd. (6220.TWO) Income Statement Analysis – Financial Results
Ventura Cannabis & Wellness Corporation (CVHIF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.venturacanna.com
About Ventura Cannabis & Wellness Corporation
Ventura Cannabis & Wellness Corporation operates as a vertically integrated cannabis product company in California. The company was formerly known as BLVD Centers Corporation and changed its name to Ventura Cannabis & Wellness Corporation in February 2019. The company was incorporated in 2013 and is headquartered in Los Angeles, California.
Metric | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|
Revenue | 10.63M | 24.55M | 24.35M | 22.39M | 13.44M | 684.45K | 0.00 |
Cost of Revenue | 7.47M | 21.49M | 17.73M | 10.13M | 6.24M | 292.71K | 0.00 |
Gross Profit | 3.16M | 3.06M | 6.62M | 12.26M | 7.20M | 391.74K | 0.00 |
Gross Profit Ratio | 29.72% | 12.47% | 27.18% | 54.74% | 53.55% | 57.23% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 3.75M | 2.23M | 2.54M | 4.89M | 1.89M | 74.49K | 59.41K |
Selling & Marketing | 75.00K | 6.08K | 597.74K | 3.73M | 2.64M | 475.87K | 56.65K |
SG&A | 3.82M | 5.37M | 8.41M | 23.60M | 8.77M | 2.04M | 49.72K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 4.88M | 5.37M | 8.41M | 23.60M | 8.98M | 2.04M | 49.72K |
Cost & Expenses | 11.58M | 26.86M | 26.14M | 33.73M | 15.22M | 2.33M | 49.72K |
Interest Income | 0.00 | 643.66K | 529.94K | 376.47K | 12.42K | 0.00 | 0.00 |
Interest Expense | 913.21K | 643.13K | 680.00K | 500.00K | 20.00K | 0.00 | 0.00 |
Depreciation & Amortization | 1.13M | 561.88K | 569.71K | 1.03M | 374.82K | 4.38K | 116.06K |
EBITDA | -103.00K | -1.74M | -1.77M | -20.58M | -329.00K | -1.64M | 16.73K |
EBITDA Ratio | -0.97% | -7.10% | -5.02% | -46.04% | -11.76% | -240.33% | 0.00% |
Operating Income | -1.28M | -2.31M | -1.79M | -11.34M | -1.96M | -1.65M | -49.72K |
Operating Income Ratio | -12.03% | -9.39% | -7.36% | -50.64% | -14.55% | -240.97% | 0.00% |
Total Other Income/Expenses | -475.64K | -240.44K | -1.80M | -10.65M | 647.00K | 232.67K | -49.62K |
Income Before Tax | -1.75M | -2.95M | -2.48M | -21.98M | -1.80M | -1.65M | -99.34K |
Income Before Tax Ratio | -16.50% | -12.03% | -10.20% | -98.18% | -13.39% | -240.97% | 0.00% |
Income Tax Expense | 0.00 | 0.00 | 1.00 | 306.54K | 240.03K | 0.00 | -116.06K |
Net Income | -1.73M | -2.95M | -2.48M | -22.29M | -1.56M | -1.65M | -99.34K |
Net Income Ratio | -16.25% | -12.03% | -10.20% | -99.55% | -11.61% | -240.97% | 0.00% |
EPS | -0.05 | -0.08 | -0.08 | -0.71 | -0.07 | -0.25 | -0.15 |
EPS Diluted | -0.05 | -0.08 | -0.08 | -0.71 | -0.07 | -0.25 | -0.15 |
Weighted Avg Shares Out | 36.16M | 34.86M | 31.69M | 31.28M | 23.40M | 6.69M | 668.14K |
Weighted Avg Shares Out (Dil) | 36.16M | 34.86M | 31.69M | 31.28M | 23.40M | 6.69M | 668.14K |
Source: https://incomestatements.info
Category: Stock Reports